The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Molecular correlation of the activity of evofosfamide (EVO) in combination with sunitinib (SUN) in pancreatic Neuroendocrine Tumors (pNETs) in the SUNEVO GETNE Trial.
 
Carlos López-López
Honoraria - Ipsen; Novartis; Pfizer; Roche
Consulting or Advisory Role - Ipsen; Pfizer; Roche
Research Funding - Ipsen; Pfizer; Roche
Travel, Accommodations, Expenses - Ipsen; Pfizer; Roche
 
Teresa Alonso Gordoa
Consulting or Advisory Role - Astellas Pharma; Bayer; Bristol-Myers Squibb; Eisai; Ipsen; Janssen-Cilag; MSD Oncology; Novartis; Pfizer; Roche; Sanofi
Research Funding - Ipsen; Pfizer; Roche
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Ipsen; Pfizer; Sanofi
 
Marta Benavent
Consulting or Advisory Role - Ipsen; Novartis; Pfizer
Travel, Accommodations, Expenses - Ipsen; Novartis; Pfizer
 
Jaume Capdevila
Consulting or Advisory Role - Advanced Accelerator Applications; Bayer; Eisai; Exelixis; Ipsen; Merck Serono; Novartis; Pfizer; Sanofi
Speakers' Bureau - Bayer; Eisai; Ipsen; Merck Serono; Novartis; Pfizer; Sanofi
Research Funding - Advanced Accelerator Applications (Inst); AstraZeneca (Inst); Bayer (Inst); Eisai (Inst); Ipsen (Inst); Ipsen (Inst); Novartis (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Eisai; Ipsen; Pfizer
 
Alex Teule
Consulting or Advisory Role - Advanced Accelerator Applications; Ipsen; Novartis; Pfizer
Travel, Accommodations, Expenses - AstraZeneca; Ipsen; Novartis
 
Ana Custodio
No Relationships to Disclose
 
Isabel Sevilla
Consulting or Advisory Role - Ipsen; Lilly; Novartis; Pfizer
Travel, Accommodations, Expenses - Ipsen
 
Maria Santos
No Relationships to Disclose
 
J. Lanillos
No Relationships to Disclose
 
Cristina Rodríguez-Antona
Research Funding - Pfizer
 
Rocio Garcia-Carbonero
Honoraria - Advanced Accelerator Applications; Advanz Pharma; AstraZeneca (I); Boehringer Ingelheim (I); BRISTOL-MYERS SQUIBB; Bristol-Myers Squibb (I); Gilead Sciences (I); HMP; Ipsen; Lilly (I); MERCK; Merck (I); Midatech Pharma; NOVARTIS; PFIZER; PharmaMar; PharmaMar (I); Pierre Fabre; ROCHE; Roche (I); Sanofi; SERVIER; SERVIER (I); Sysmex (I)
Consulting or Advisory Role - Advanced Accelerator Applications; HMP; Ipsen; Novartis; Pfizer
Speakers' Bureau - Ipsen; Pfizer
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); MSD (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Merck; Roche
 
Enrique Grande
Honoraria - Advanced Accelerator Applications; Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Celgene; Eisai; Eusa Pharma; Genzyme; IPSEN; Janssen-Cilag; Lexicon; Lilly; MSD; Novartis; Pfizer; Pierre Fabre; Roche
Consulting or Advisory Role - Bristol-Myers Squibb; Ipsen; MSD; Pfizer; Roche; Roche
Research Funding - AstraZeneca (Inst); Ipsen (Inst); Molecular Templates (Inst); Pfizer (Inst); Roche
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Janssen-Cilag; Pfizer; Roche/Genentech